CrushSCI.com
206.4平均天数
140中位天数
89最短天数
445最长天数
7042025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

445 天

Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner

作者
Zhe Fu; Victoria Jackson-Patel; Kathryn Farrand; Alisha R Dabb; Xiaojing Lin; Emily Liu; Amir Ashoorzadeh; Jeff B Smaill; Ian F Hermans; Adam V Patterson展开收起
作者单位
1. Malaghan Institute of Medical Research, Wellington, New Zealand; 2. Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New Zealand展开收起
官方全文证据 DOI 网页
113 天

Neutrophil–epithelial niches arrest B-cell maturation in dysfunctional tertiary lymphoid structures of gastric cancer neoadjuvant immunochemotherapy

作者
Chen Wei; Qiang Fu; Hejia Wei; Hao Zhai; Shuailei Dong; Xiaoqing Ma; Liangyu Bie; Yijie Ma; Yuanyuan Wang; Qingxin Xia; Suxia Luo; Ning Li展开收起
作者单位
1. Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China; 2. Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 3. School of First Clinical College, Shenyang Medical College, Shenyang, Liaoning, China; 4. Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China展开收起
官方全文证据 DOI 网页
89 天

Engineering T cell-engaging bispecific antibodies targeting KRAS G12V neoantigen across HLA-A*11:01 and HLA-A*03:01

作者
Xiaojing Wu; Clara Effenberger; Yosuke Matsushita; Hiroki Tanaka; Yu Ishii; Suyong Re; Saki Matsumoto; Satoshi Nagayama; Yusuke Nakamura; Kazuma Kiyotani展开收起
作者单位
1. Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 2. Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan; 3. Laboratory of Biofunctional Molecular Medicine, Center for Drug Design Research (CDDR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 4. Laboratory of Molecular Diagnostics and Therapeutics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 5. Laboratory of In Silico Design, Artificial Intelligence Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 6. Department of Surgery, Uji-Tokushukai Medical Center, Uji, Kyoto, Japan; 7. Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan展开收起
官方全文证据 DOI 网页
140 天

Distinct genomic landscapes of mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancer depending on tumor mutation burden (TMB) levels

作者
Jingyuan Wang; Joanne Xiu; Alex P Farrell; Francesca Battaglin; Hiroyuki Arai; Yan Yang; Shivani Soni; Wu Zhang; Joshua Millstein; Anthony F Shields; Axel Grothey; Benjamin A Weinberg; John Marshall; Emil Lou; Moh’d Khushman; Davendra P S Sohal; Michael J Hall; Tianshu Liu; Matthew James Oberley; David Spetzler; Heinz-Josef Lenz展开收起
作者单位
1. Department of Medical Oncology, Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China; 2. Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; 3. Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Xiamen, Fujian; 4. Caris Life Sciences, Phoenix, Arizona, USA; 5. Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; 6. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA; 7. Gastrointestinal Cancer Research, West Cancer Center and Research Institute, Germantown, Tennessee, USA; 8. Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA; 9. Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA; 10. Departments of Medical Oncology, Washington University in St. Louis/Siteman Cancer Center, St. Louis, Missouri, USA; 11. University of Cincinnati, Cincinnati, Ohio, USA; 12. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA展开收起
官方全文证据 DOI 网页
245 天

Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation

作者
Mamduh Khateb; Raina Jung; Patrick Hadley; Stav Leibou; Zhiya Yu; Aaron J Dinerman; Victoria Dulemba; Billel Gasmi; Noam Levin; Sanghyun Peter Kim; Aarushi Bhasin; Deepali Bhat; Sivasish Sindiri; Jared J Gartner; Todd D Prickett; Tiffany Benzine; Shahram Farid; Maria Parkhurst; Hyunmi Halas; Guangzhe Ge; Yaqiang Cao; Keji Zhao; James C Yang; Paul Robbins; Frank J Lowery; Sri Krishna; Theo Heller; Daniel Mcvicar; Steven A Rosenberg; Nicholas D Klemen展开收起
作者单位
1. Surgery Branch, NCI, Bethesda, Maryland, USA; 2. Systems Biology Center, NHLBI, Bethesda, Maryland, USA; 3. NIDDK, Bethesda, Maryland, USA; 4. NCI/CCR, Bethesda, Maryland, USA展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。